Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

ERT’s Centralized LCI Services improve data quality to measure disease progression in respiratory clinical trials

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today introduced an advanced respiratory clinical trial solution to centrally capture, measure and analyze Lung Clearance Index data, in near real-time, to assess lung performance with more precision than traditional spirometry measures.

26 May 2017

Study provides new understanding of silent gene changes and genetic complexity of cystic fibrosis

Cystic fibrosis is a common life-shortening inherited disease that affects over 70,000 people worldwide, the majority of whom are children and young adults.

18 May 2017

FDA expands approval for cystic fibrosis drug to treat additional rare gene mutations

The U.S. Food and Drug Administration today expanded the approved use of Kalydeco (ivacaftor) for treating cystic fibrosis.

18 May 2017

Scientists grow and purify earliest lung progenitors from human stem cells

Human lungs, like all organs, begin their existence as clumps of undifferentiated stem cells. But in a matter of months, the cells get organized. They gather together, branch and bud, some forming airways and others alveoli, the delicate sacs where our bodies exchange oxygen for carbon dioxide.

3 May 2017

Shire and Parion Sciences to collaborate on P-321 for ophthalmic indications

Shire plc and Parion Sciences, Inc. have announced they have entered into an agreement granting Shire exclusive worldwide rights to develop and commercialize P-321. Shire will lead development of P-321, an investigational epithelial sodium channel (ENaC) inhibitor for the potential treatment of dry eye disease in adults, with the opportunity for Parion to co-fund.

3 May 2017

New technique dramatically accelerates search for new cancer treatments

A new technique developed at the University of Virginia School of Medicine will let a single cancer research lab do the work of dozens, dramatically accelerating the search for new treatments and cures.

26 Apr 2017

Researchers discover molecular compound that targets nucleus of allergen-sensitized cells

Transcription factors, the tiny proteins that switch genes on or off in the nucleus of cells, are considered unreachable molecular targets for drugs attempting to treat medical conditions.

18 Apr 2017

TSRI scientists develop easy method for synthesizing compounds with potential to treat lung disorders

Chemists at The Scripps Research Institute have developed a broad and strikingly easy method for synthesizing a class of molecules that have demonstrated value as pharmaceuticals.

17 Apr 2017

New strategy in antimicrobial peptides holds promise for combating multi-drug resistant bacteria

In an article published recently in Plos One, researchers from INRS-Institut Armand-Frappier Research Centre reported a strategy that could lead to the discovery of new cationic antimicrobial peptides (CAMPs) with greatly enhanced antimicrobial properties.

5 Apr 2017

Researchers discover how fat soluble vitamins may offer viable solution for treating cystic fibrosis

Researchers from Queen's University Belfast have discovered why antibiotics for treating people with cystic fibrosis are becoming less effective and how fat soluble vitamins might offer a viable solution.

27 Mar 2017

New UBC research reveals clues to how bacteria proliferates in lungs of cystic fibrosis patients

New UBC research on bacteria that cause major problems for those with cystic fibrosis reveals clues as to how it proliferates for so long in the lungs and offers new ideas for treatments to explore.

27 Mar 2017

Stem cell therapy can reduce lung inflammation in mouse model of COPD and cystic fibrosis

A new study has found that stem cell therapy can reduce lung inflammation in an animal model of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. Although, still at a pre-clinical stage, these findings have important potential implications for the future treatment of patients.

25 Mar 2017

Scientists map three-dimensional structure of protein that causes cystic fibrosis

Scientists at The Rockefeller University have mapped the three-dimensional structure for one of the more notorious disease-causing molecules in the human body: the protein responsible for the genetic disorder cystic fibrosis. And it looks fishy.

23 Mar 2017

Researchers uncover major clue to how mucus becomes abnormal in CF airways

People with cystic fibrosis (CF) suffer repeated lung infections because their airway mucus is too thick and sticky to keep bacteria, viruses, and other pathogens from causing chronic infection.

23 Mar 2017

Phage therapy could offer safe and effective treatment option for Cystic Fibrosis lung infections

Scientists from the University of Liverpool have shown that phage therapy could offer a safe and effective alternative to antibiotics in the treatment of Cystic Fibrosis lung infections.

13 Mar 2017

McMaster researchers find new way to combat world's worst infectious diseases

McMaster University researchers have found a new way to treat the world's worst infectious diseases, the superbugs that are resistant to all known antibiotics.

6 Mar 2017

Innovative ways to target antibiotic resistance in short term

There has been much recent talk about how to target the rising tide of antibiotic resistance across the world, one of the biggest threats to global health today.

3 Mar 2017

Researcher examines scarring process in hope of preventing chronic lung transplant rejection

For patients affected by lung diseases such as pulmonary fibrosis, chronic obstructive pulmonary disease, cystic fibrosis and others, cures for their diseases are incredibly rare, if not nonexistent.

2 Mar 2017

New report expresses ethical concerns about use of non-invasive prenatal testing

A new report on non-invasive prenatal testing by the UK's Nuffield Council on Bioethics expresses concerns about the way the test is being sold by private providers.

1 Mar 2017

Diagnosing Infections Through Molecules in Patient Breath

Over the past couple of decades, the analytical technology and the clinical microbiology insight needed to create a breath test for infections has seen a considerable number of advances and there are now numerous research teams focused on evaluating patient breath as a diagnostic fluid for infectious diseases. Significant challenges still need to be overcome.

From Pittcon 27 Feb 2017

Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

ERT’s Centralized LCI Services improve data quality to measure disease progression in respiratory clinical trials

Study provides new understanding of silent gene changes and genetic complexity of cystic fibrosis

FDA expands approval for cystic fibrosis drug to treat additional rare gene mutations

Scientists grow and purify earliest lung progenitors from human stem cells

Shire and Parion Sciences to collaborate on P-321 for ophthalmic indications

New technique dramatically accelerates search for new cancer treatments

Researchers discover molecular compound that targets nucleus of allergen-sensitized cells

TSRI scientists develop easy method for synthesizing compounds with potential to treat lung disorders

New strategy in antimicrobial peptides holds promise for combating multi-drug resistant bacteria

Researchers discover how fat soluble vitamins may offer viable solution for treating cystic fibrosis

New UBC research reveals clues to how bacteria proliferates in lungs of cystic fibrosis patients

Stem cell therapy can reduce lung inflammation in mouse model of COPD and cystic fibrosis

Scientists map three-dimensional structure of protein that causes cystic fibrosis

Researchers uncover major clue to how mucus becomes abnormal in CF airways

Phage therapy could offer safe and effective treatment option for Cystic Fibrosis lung infections

McMaster researchers find new way to combat world's worst infectious diseases

Innovative ways to target antibiotic resistance in short term

Researcher examines scarring process in hope of preventing chronic lung transplant rejection

New report expresses ethical concerns about use of non-invasive prenatal testing

Diagnosing Infections Through Molecules in Patient Breath

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in